Clinical Characteristics and Metabolic Predictors of Rapid Responders to Dipeptidyl Peptidase-4 Inhibitor as an Add-on Therapy to Sulfonylurea and Metformin

BACKGROUND: Dipeptidyl peptidase-4 (DPP-4) inhibitor add-on therapy is a new option for patients with inadequately controlled type 2 diabetes who are taking combined metformin and sulfonylurea (SU). We evaluated the efficacy and safety of this triple therapy and the characteristics of rapid responde...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Diabetes Metab J
Main Authors: Kim, Ye An, Yoo, Won Sang, Hong, Eun Shil, Ku, Eu Jeong, Park, Kyeong Seon, Lim, Soo, Cho, Young Min, Park, Kyong Soo, Jang, Hak Chul, Choi, Sung Hee
Format: Artigo
Sprog:Inglês
Udgivet: Korean Diabetes Association 2015
Fag:
Original Article
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4696985/
https://ncbi.nlm.nih.gov/pubmed/26616595
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4093/dmj.2015.39.6.489
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker